Roche's von Prondzynski optimistic over Igen
This article was originally published in Clinica
Executive Summary
Last week, a US appeal court in Richmond, Virginia, heard oral arguments on Roche Diagnostics' appeal against a ruling last year ordering it to pay $505m damages to Igen International. Following the hearing, Igen's share price plunged by 18% to $32.70.